• Inicio
  • Formações
  • Formação à Medida
  • News & Trends
  • Sobre nós
  • Contacto

EC MDR Guidance on New Safety and Clinical Performance Summary

The main purpose of this document is to provide guidance on the presentation,content and validation of the SSCP. The word “shall” is used when there is a corresponding “shall” in the MDR, otherwise “should” or “recommended” etc. is used indicating the interpretation of the MDR.

 

MDCG 2019-9 Summary of safety and clinical performance A guide for manufacturers and notified bodies

News & Trends

Procurar

Recentes

  • FARMACOVIGILÂNCIA avançada: ““Excelente! Organizada e abrangente !”
  • Study on the deployment of AI in healthcare Final report
  • Boas Práticas de Fabrico . GMP 2025: “Formação foi muito útil a nível de aplicabilidade “
  • Conducting Clinical Trials With Decentralized Elements. Guidance for Industry, Investigators, and Other Interested Parties
  • COMMISSION IMPLEMENTING REGULATION (EU) 2025/2086 of 17 October 2025
  • Main root causes of shortages: Analysis of reported root causes during 2022 & 2023
  • EUDAMED Release note v 2.18.0
  • The ICH E2D(R1) Guideline reaches Step 4 of the ICH Process

91 257 00 03 (Chamada para a rede móvel nacional)
info@formiventos.com

  • Follow
  • CLIENTES & TESTIMONIALS
  • ASSOCIAÇÕES OFICIAIS
  • CERTIFICAÇÕES E CREDITAÇÕES
  • ADVISORY BOARD
  • Política de Privacidade
  • Contacto